Skip to main content
Log in

Diminished ovarian reserve in Behçet’s disease patients

  • Brief Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study aims to assess ovarian reserve markers in Behçet's disease (BD) patients. Ten BD and 22 healthy controls were evaluated for ovarian reserve by examining the levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, inhibin B, total morning testosterone, prolactin, thyroid-stimulating hormone (TSH), and antral follicle count. Anti-Müllerian hormone (AMH) was measured using two different enzyme-linked immunosorbent assay (ELISA) kits. Demographic data, menstrual abnormalities, disease parameters, and treatments were also analyzed. The median current age was similar in BD patients and controls (34 (20–40) vs. 31.3 (20–42) years, p = 0.33). A positive correlation was observed between the AMH Gen II ELISA and AMH/MISAnshLabs ELISA assays in the BD patients (r = +0.98; p < 0.0001) and healthy controls (r = +0.93; p < 0.0001). The mean AMH by Gen II (0.93 ± 0.8 vs. 2.59 ± 1.8 ng/mL, p = 0.01) and AMH/MIS AnshLabs ELISA (1.07 ± 0.86 vs. 2.51 ± 1.8 ng/mL, p = 0.02) were significantly reduced in the BD patients versus controls. A trend of decreased AMH (<1.0 ng/mL) was observed in BD patients compared to that in the controls (50 vs. 19 %, p = 0.09) using either kits. The mean FSH was significantly higher in the BD patients compared to that in the controls (9.1 ± 3.6 vs. 6.5 ± 2.7, p = 0.04). No differences were found for the other ovarian parameters in both groups (p > 0.05). Current disease activity was only observed in BD patients with a low AMH level; however, there was no statistical significance (40 vs. 0 %, p = 0.44). Cyclophosphamide use was reported in only one patient with a low AMH and high FSH level. The present study was the first to suggest that BD patients may have diminished ovarian reserve. The contribution of disease activity remains to be determined.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Aikawa NE, Gonçalves C, Silva CA, Gonçalves C, Bonfá E, de Carvalho JF (2001) Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet’s disease. Rheumatol Int 31:1097–1099

    Article  Google Scholar 

  2. Silva CA, Brunner HI (2007) Gonadal functioning and preservation of reproductive fitness with juvenile systemic lupus erythematosus. Lupus 16:593–599

    Article  CAS  PubMed  Google Scholar 

  3. Silva CA, Yamakami LY, Aikawa NE, Araujo DB, Carvalho JF, Bonfá E (2014) Autoimmune primary ovarian insufficiency. Autoimmun Rev 13:427–430

    Article  CAS  PubMed  Google Scholar 

  4. Silva CA, Bonfa E, Østensen M (2010) Maintenance of fertility in patients with rheumatic diseases needing antiinflammatory and immunosuppressive drugs. Arthritis Care Res (Hoboken) 62:1682–1690

    Article  Google Scholar 

  5. Ostensen M, Brucato A, Carp H et al (2011) Pregnancy and reproduction in autoimmune rheumatic diseases. Rheumatology (Oxford) 50:657–664

    Article  Google Scholar 

  6. Aikawa NE, Sallum AM, Pereira RM et al (2012) Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy. Clin Exp Rheumatol 30:445–449

    CAS  PubMed  Google Scholar 

  7. Silva CA, Leal MM, Leone C et al (2002) Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus. Lupus 11:419–425

    Article  CAS  PubMed  Google Scholar 

  8. Silva CA, Hilário MO, Febrônio MV et al (2007) Risk factors for amenorrhea in juvenile systemic lupus erythematosus (JSLE): a Brazilian multicentre cohort study. Lupus 16:531–536

    Article  CAS  PubMed  Google Scholar 

  9. Medeiros P, Febrônio M, Bonfá E, Borba E, Takiuti A, Silva CA (2009) Menstrual and hormonal alterations in juvenile systemic lupus erythematosus. Lupus 18:38–43

    Article  CAS  PubMed  Google Scholar 

  10. Aikawa NE, Sallum AM, Leal MM, Bonfá E, Pereira RM, Silva CA (2010) Menstrual and hormonal alterations in juvenile dermatomyositis. Clin Exp Rheumatol 28:571–575

    CAS  PubMed  Google Scholar 

  11. Uzunaslan D, Saygin C, Hatemi G, Tascilar K, Yazici H (2014) No appreciable decrease in fertility in Behcet’s syndrome. Rheumatology (Oxford) 53:828–833

    Article  CAS  Google Scholar 

  12. Çil AP, Karabulut AA, Koçak M (2010) Assessment of ovarian stromal artery Doppler characteristics and serum hormone levels in patients with Behçet disease. Diagn Interv Radiol 16:288–292

    PubMed  Google Scholar 

  13. (1990) Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease. Lancet 335:1078-1080

  14. Satwik R, Kochhar M, Gupta SM, Majumdar A (2012) Anti-Mullerian hormone cut-off values for predicting poor ovarian response to exogenous ovarian stimulation in in-vitro fertilization. J Hum Reprod Sci 5:206–212

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Hendriks DJ, Kwee J, Mol BW, te Velde ER, Broekmans FJ (2007) Ultrasonography as a tool for the prediction of outcome in IVF patients: a comparative meta-analysis of ovarian volume and antral follicle count. Fertil Steril 87:764–775

    Article  PubMed  Google Scholar 

  16. Neves FS, Moraes JC, Kowalski SC, Goldenstein-Schainberg C, Lage LV, Gonçalves CR (2007) Cross-cultural adaptation of the Behçet’s Disease Current Activity Form (BDCAF) to Brazilian Portuguese language. Clin Rheumatol 26:1263–1267

    Article  CAS  PubMed  Google Scholar 

  17. Freour T, Masson D, Mirallie S et al (2008) Active smoking compromises IVF outcome and affects ovarian reserve. Reprod Biomed Online 16:96–102

    Article  PubMed  Google Scholar 

  18. Clark CA, Laskin CA, Cadesky K (2014) Anti-Mullerian hormone: reality check. Hum Reprod 29:184–185

    Article  PubMed  Google Scholar 

  19. Practice Committee of the American Society for Reproductive Medicine (2012) Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril 98:1407–1415

    Article  Google Scholar 

  20. Seifer DB, Golub ET, Lambert-Messerlian G et al (2009) Variations in serum Müllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril 92:1674–1678

    Article  PubMed Central  PubMed  Google Scholar 

  21. Bleil ME, Gregorich SE, Adler NE, Sternfeld B, Rosen MP, Cedars MI (2014) Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling women. Fertil Steril 101:199–207

    Article  PubMed  Google Scholar 

  22. Silva CA, Cocuzza M, Borba EF, Bonfá E (2012) Cutting-edge issues in autoimmune orchitis. Clin Rev Allergy Immunol 42:256–263

    Article  CAS  PubMed  Google Scholar 

  23. Silva CA, Hallak J, Pasqualotto FF, Barba MF, Saito MI, Kiss MH (2002) Gonadal function in male adolescents and young males with juvenile onset systemic lupus erythematosus. J Rheumatol 29:2000–2005

    PubMed  Google Scholar 

  24. Soares PM, Borba EF, Bonfa E, Hallak J, Correa AL, Silva CA (2007) Gonad evaluation in male systemic lupus erythematosus. Arthritis Rheum 56:2352–2361

    Article  PubMed  Google Scholar 

  25. Suehiro RM, Borba EF, Bonfa E et al (2008) Testicular Sertoli cell function in male systemic lupus erythematosus. Rheumatology 47:1692–1697

    Article  CAS  PubMed  Google Scholar 

  26. Moraes AJ, Pereira RM, Cocuzza M, Casemiro R, Saito O, Silva CA (2008) Minor sperm abnormalities in young male post-pubertal patients with juvenile dermatomyositis. Braz J Med Biol Res 41:1142–1147

    Article  CAS  PubMed  Google Scholar 

  27. Morales AJ, Bonfa E, Cocuzza M, Borges CT, Saito O, Silva CA (2010) Gonad evaluation in male dermatomyositis. A pilot study. Clin Exp Rheumatol 28:441–442

    Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP# 11/12471-2 to CAS), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPQ #301411/2009-3 to EB and #302724/2011-7 to CAS), Federico Foundation (to EB and CAS), and Núcleo de Apoio à Pesquisa “Saúde da Criança e do Adolescente” da USP (NAP-CriAd-SP) to CAS. We thank Elaine P. Leon and Vilma T. Viana for their technical support and Dr. Ulysses Doria Filho for the statistical analysis.

Disclosures

Andrea R.S. Mont’Alverne, Lucas Y.S. Yamakami, Célio R. Gonçalves, Edmund C. Baracat, Eloisa Bonfá, and Clovis A. Silva have no conflict of interest to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eloisa Bonfá.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mont’Alverne, A.R.S., Yamakami, L.Y.S., Gonçalves, C.R. et al. Diminished ovarian reserve in Behçet’s disease patients. Clin Rheumatol 34, 179–183 (2015). https://doi.org/10.1007/s10067-014-2680-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-014-2680-5

Keywords

Navigation